These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2476831

  • 1. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration.
    Johnson MP, Nichols DE.
    Pharmacol Biochem Behav; 1989 May; 33(1):105-8. PubMed ID: 2476831
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
    Battaglia G, Yeh SY, De Souza EB.
    Pharmacol Biochem Behav; 1988 Feb; 29(2):269-74. PubMed ID: 2452449
    [Abstract] [Full Text] [Related]

  • 5. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
    Nash JF, Arora RC, Schreiber MA, Meltzer HY.
    Biochem Pharmacol; 1991 Jan 01; 41(1):79-84. PubMed ID: 1702633
    [Abstract] [Full Text] [Related]

  • 6. Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat.
    Hekmatpanah CR, McKenna DJ, Peroutka SJ.
    Neurosci Lett; 1989 Sep 25; 104(1-2):178-82. PubMed ID: 2573011
    [Abstract] [Full Text] [Related]

  • 7. Behavioral, biochemical and neurotoxicological actions of the alpha-ethyl homologue of p-chloroamphetamine.
    Johnson MP, Huang XM, Oberlender R, Nash JF, Nichols DE.
    Eur J Pharmacol; 1990 Nov 20; 191(1):1-10. PubMed ID: 1982656
    [Abstract] [Full Text] [Related]

  • 8. Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat.
    O'Loinsigh ED, Boland G, Kelly JP, O'Boyle KM.
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr 20; 25(3):621-38. PubMed ID: 11371001
    [Abstract] [Full Text] [Related]

  • 9. Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity.
    Logan BJ, Laverty R, Sanderson WD, Yee YB.
    Eur J Pharmacol; 1988 Aug 02; 152(3):227-34. PubMed ID: 2906000
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA).
    Steele TD, Katz JL, Ricaurte GA.
    Brain Res; 1992 Sep 04; 589(2):349-52. PubMed ID: 1382813
    [Abstract] [Full Text] [Related]

  • 11. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD, Nichols DE, Yim GK.
    Biochem Pharmacol; 1987 Jul 15; 36(14):2297-303. PubMed ID: 2886126
    [Abstract] [Full Text] [Related]

  • 12. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
    Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB.
    J Pharmacol Exp Ther; 1989 Jun 15; 249(3):713-20. PubMed ID: 2471824
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity.
    Brodkin J, Malyala A, Nash JF.
    Pharmacol Biochem Behav; 1993 Jul 15; 45(3):647-53. PubMed ID: 8101380
    [Abstract] [Full Text] [Related]

  • 15. Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue.
    Johnson MP, Huang XM, Nichols DE.
    Pharmacol Biochem Behav; 1991 Dec 15; 40(4):915-22. PubMed ID: 1726189
    [Abstract] [Full Text] [Related]

  • 16. Reduction of [3H]6-nitroquipazine-labelled 5-hydroxytryptamine uptake sites in rat brain by 3,4-methylenedioxymethamphetamine.
    Hashimoto K, Goromaru T.
    Fundam Clin Pharmacol; 1990 Dec 15; 4(6):635-41. PubMed ID: 1710592
    [Abstract] [Full Text] [Related]

  • 17. Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity.
    Johnson M, Stone DM, Bush LG, Hanson GR, Gibb JW.
    Eur J Pharmacol; 1989 Feb 28; 161(2-3):181-8. PubMed ID: 2470597
    [Abstract] [Full Text] [Related]

  • 18. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys.
    Kleven MS, Woolverton WL, Seiden LS.
    Brain Res; 1989 May 29; 488(1-2):121-5. PubMed ID: 2472850
    [Abstract] [Full Text] [Related]

  • 19. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.
    Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS.
    J Pharmacol Exp Ther; 1987 Apr 29; 241(1):338-45. PubMed ID: 2883295
    [Abstract] [Full Text] [Related]

  • 20. Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices.
    Johnson MP, Hoffman AJ, Nichols DE.
    Eur J Pharmacol; 1986 Dec 16; 132(2-3):269-76. PubMed ID: 2880735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.